BACKGROUND: The aim of this paper was to analyze differences in clinical presentation, management, and short-term outcomes between vascular patients in two consecutive COVID-19 “waves” (i.e., first wave [W1], second wave [W2]) and the corresponding sub-population of COVID-19 positive (C19pos) patients. METHODS: Data from regional Lombardy (Italy) multicenter registry during W1 (March 8, 2020-May 3, 2020) and W2 (October 3, 2020-January 21, 2021) were collected. The primary outcome was 30-day mortality for the entire cohort. Secondary outcomes were 30-day postoperative complication and major amputation rates. Propensity score matching was used to compare waves populations. RESULTS: Data on 1276 patients (W1: N.=659; W2: N.=617) were collected, of which 121 (18.4%) and 50 (8.1%) patients were C19pos in W1 and W2, respectively (P<0.001). Considering the matched entire cohort, elective treatments increased during W2 (11.2% vs. 54.0%, P<0.001). Thirty-day mortality was lower in W2 (12% vs. 5.8%, P=0.001), 30-day postoperative complication rate improved (19.1% vs. 12.0%, P=0.003), and major amputation rates decreased (10.9% vs. 1.1%, P<0.001). Considering the matched C19pos cohorts, thirty-day mortality was similar in both waves (34.9% vs. 32.0%, P=0.786), 30-day moderate postoperative complications reduced in W2 (22.9% vs. 4.0%, P=0.033), and major amputation rates were similar. CONCLUSIONS: Although 30-day outcomes improved during W2 for the entire cohort, C19pos patients experienced similar 30-day mortality and major amputation rates comparing the two waves. Analyzing the pandemic’s impact and continued surveillance seems paramount to improve the outcomes of vascular patients.

A propensity score matching analysis comparing vascular patients in two different COVID-19 waves / Bissacco, D.; Bellosta, R.; Domanin, M.; Primo, R.; Mandigers, T. J.; Savarè, L.; Ieva, F.; Piffaretti, G.; Trimarchi, S.; Briolini, F.; Cefali, P.; Caronno, R.; Arzini, A.; Diaco, D.; Baratta, V.; Aiello, S.; Rossi, G.; Molinari, A. C.; Pirrelli, S.; Giovannini, F.; Socrate, A. M.; Ferraris, M.; Silvestro, A.; Canu, G.; Costantini, E.; Logaldo, D.; Romani, F.; Lista, A.; D'Alessio, I.; Frigerio, D.; Busoni, C.; Setti, M.; Mezzetti, R.; Sala, P.; Bassi, L.; Casana, R.; Luzzani, L.; Pegorer, M. A.; Attisani, L.; Carugati, C.; Vescovi, M.; Trabattoni, P.; Zoli, S.; Rignano, A.; Magri, C.; Vandone, P.; Losa, S.; Civilini, E.; Nano, G.; Mazzaccaro, D.; Tolva, V.; Lanza, G.; Lanza, J.; Curci, R.; Simonetti, G.; Lomazzi, C.; Grassi, V.; de Kort, J.; Chiesa, R.; Kahlberg, A.; Mascia, D.; Dallatana, R.; Carmo, M.; Ragni, F.; Marone, E. M.; Bozzani, A.; Castelli, P.; Tozzi, M.; Franchin, M.; Bonardelli, S.; Lussardi, G.; Segramora, V.; Deleo, G.; Crippa, M.; Porretta, T.; Viani, M.; Stegher, S.; For-Esti, D.. - In: ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. - ISSN 1824-4777. - 31:1(2024), pp. 19-26. [10.23736/S1824-4777.23.01647-9]

A propensity score matching analysis comparing vascular patients in two different COVID-19 waves

Chiesa R.;Kahlberg A.;
2024-01-01

Abstract

BACKGROUND: The aim of this paper was to analyze differences in clinical presentation, management, and short-term outcomes between vascular patients in two consecutive COVID-19 “waves” (i.e., first wave [W1], second wave [W2]) and the corresponding sub-population of COVID-19 positive (C19pos) patients. METHODS: Data from regional Lombardy (Italy) multicenter registry during W1 (March 8, 2020-May 3, 2020) and W2 (October 3, 2020-January 21, 2021) were collected. The primary outcome was 30-day mortality for the entire cohort. Secondary outcomes were 30-day postoperative complication and major amputation rates. Propensity score matching was used to compare waves populations. RESULTS: Data on 1276 patients (W1: N.=659; W2: N.=617) were collected, of which 121 (18.4%) and 50 (8.1%) patients were C19pos in W1 and W2, respectively (P<0.001). Considering the matched entire cohort, elective treatments increased during W2 (11.2% vs. 54.0%, P<0.001). Thirty-day mortality was lower in W2 (12% vs. 5.8%, P=0.001), 30-day postoperative complication rate improved (19.1% vs. 12.0%, P=0.003), and major amputation rates decreased (10.9% vs. 1.1%, P<0.001). Considering the matched C19pos cohorts, thirty-day mortality was similar in both waves (34.9% vs. 32.0%, P=0.786), 30-day moderate postoperative complications reduced in W2 (22.9% vs. 4.0%, P=0.033), and major amputation rates were similar. CONCLUSIONS: Although 30-day outcomes improved during W2 for the entire cohort, C19pos patients experienced similar 30-day mortality and major amputation rates comparing the two waves. Analyzing the pandemic’s impact and continued surveillance seems paramount to improve the outcomes of vascular patients.
2024
COVID-19
SARS-CoV-2
Vascular surgical procedures
Patient outcome assessment
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/168978
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact